Ala. Jury Hits Sandoz For $78M In Medicaid Fraud Suit
A jury in Alabama has ruled that generic-drug maker Sandoz Inc. should be on the hook for $78.4 million for artificially boosting prescription drug prices that caused the state's Medicaid program...To view the full article, register now.
Already a subscriber? Click here to view full article